메뉴 건너뛰기




Volumn 13, Issue 1, 2014, Pages

Immune-modulatory effects of dietary Yeast Beta-1,3/1,6-D-glucan

Author keywords

Clinical trial; Immune system; Insoluble yeast glucans

Indexed keywords

(1,3), (1,6) BETA GLUCAN; BETA GLUCAN; CERULOPLASMIN; DECTIN 1; GAMMA INTERFERON; IMMUNOGLOBULIN; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEVAMISOLE; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

EID: 84900387104     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-13-38     Document Type: Review
Times cited : (204)

References (58)
  • 1
    • 0001284072 scopus 로고
    • Anticomplementary factor in fresh yeast
    • Anticomplementary factor in fresh yeast. Pillemer L, Ecker EE, J Biol Chem 1941 137 139 142
    • (1941) J Biol Chem , vol.137 , pp. 139-142
    • Pillemer, L.1    Ecker, E.E.2
  • 2
    • 0005983828 scopus 로고
    • Properdin system and immunity. II. Interaction of the properdin system with polysaccharides
    • 10.1126/science.122.3169.545 13255887
    • Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Pillemer L, Schoenberg MD, Blum L, Wurz L, Science 1955 122 3169 545 549 10.1126/science.122.3169.545 13255887
    • (1955) Science , vol.122 , Issue.3169 , pp. 545-549
    • Pillemer, L.1    Schoenberg, M.D.2    Blum, L.3    Wurz, L.4
  • 3
    • 41149148624 scopus 로고    scopus 로고
    • Beta-glucans, history, and the present: Immunomodulatory aspects and mechanisms of action
    • 10.1080/15476910802019045 18382858
    • Beta-glucans, history, and the present: immunomodulatory aspects and mechanisms of action. Novak M, Vetvicka V, J Immunotoxicol 2008 5 47 57 10.1080/15476910802019045 18382858
    • (2008) J Immunotoxicol , vol.5 , pp. 47-57
    • Novak, M.1    Vetvicka, V.2
  • 4
    • 65549091935 scopus 로고    scopus 로고
    • Glucans as biological response modifiers
    • 10.2174/187153009787582423 19275682
    • Glucans as biological response modifiers. Novak M, Vetvicka V, Endocr Metab Immune Disord Drug Targets 2009 9 67 75 10.2174/187153009787582423 19275682
    • (2009) Endocr Metab Immune Disord Drug Targets , vol.9 , pp. 67-75
    • Novak, M.1    Vetvicka, V.2
  • 5
    • 79959844941 scopus 로고    scopus 로고
    • Beta1,3-glucan: Silver bullet or hot air?
    • beta1,3-glucan: silver bullet or hot air? Vetvicka V, Vetvickova J, Open Glycoscience 2010 3 1 6
    • (2010) Open Glycoscience , vol.3 , pp. 1-6
    • Vetvicka, V.1    Vetvickova, J.2
  • 6
    • 28744441263 scopus 로고    scopus 로고
    • Natural and modified (1->3)-beta-D-glucans in health promotion and disease alleviation
    • 10.1080/07388550500376166 16419618
    • Natural and modified (1->3)-beta-D-glucans in health promotion and disease alleviation. Zekovic DB, Kwiatkowski S, Vrvic MM, Jakovljevic D, Moran CA, Crit Rev Biotechnol 2005 25 205 230 10.1080/07388550500376166 16419618
    • (2005) Crit Rev Biotechnol , vol.25 , pp. 205-230
    • Zekovic, D.B.1    Kwiatkowski, S.2    Vrvic, M.M.3    Jakovljevic, D.4    Moran, C.A.5
  • 7
    • 84878798357 scopus 로고    scopus 로고
    • Beta(1-3)-D-glucan affects adipogenesis, wound healing and inflammation
    • 10.1007/s13596-011-0024-4
    • beta(1-3)-D-glucan affects adipogenesis, wound healing and inflammation. Vetvicka V, Vetvickova J, Orient Pharm Exp Med 2011 11 169 175 10.1007/s13596-011-0024-4
    • (2011) Orient Pharm Exp Med , vol.11 , pp. 169-175
    • Vetvicka, V.1    Vetvickova, J.2
  • 8
    • 0002986082 scopus 로고
    • (1-3)-β-D-Glucans as biological response modifiers: A review of structure-functional activity relationships
    • 10.1016/0144-8617(95)00076-3
    • (1-3)-β-D-Glucans as biological response modifiers: a review of structure-functional activity relationships. Bohn JA, BeMiller JN, Carbohydr Polym 1995 28 1 3 14 10.1016/0144-8617(95)00076-3
    • (1995) Carbohydr Polym , vol.28 , Issue.1 , pp. 3-14
    • Bohn, J.A.1    Bemiller, J.N.2
  • 9
    • 15944378168 scopus 로고    scopus 로고
    • Immune recognition of fungal β-glucans
    • 10.1111/j.1462-5822.2005.00505.x 15760447
    • Immune recognition of fungal β-glucans. Brown GD, Gordon S, Cell Microbiol 2005 7 471 479 10.1111/j.1462-5822.2005.00505.x 15760447
    • (2005) Cell Microbiol , vol.7 , pp. 471-479
    • Brown, G.D.1    Gordon, S.2
  • 10
    • 76949094767 scopus 로고    scopus 로고
    • The effects of beta-glucan on human immune and cancer cells
    • 10.1186/1756-8722-2-25 19515245
    • The effects of beta-glucan on human immune and cancer cells. Chan GC, Chan WK, Sze DM, J Hematol Oncol 2009 2 25 10.1186/1756-8722-2-25 19515245
    • (2009) J Hematol Oncol , vol.2 , pp. 25
    • Chan, G.C.1    Chan, W.K.2    Sze, D.M.3
  • 11
    • 42949128589 scopus 로고    scopus 로고
    • Dietary modulation of immune function by beta-glucans
    • 10.1016/j.physbeh.2007.11.045 18222501
    • Dietary modulation of immune function by beta-glucans. Volman JJ, Ramakers JD, Plat J, Physiol Behav 2008 94 276 284 10.1016/j.physbeh.2007.11.045 18222501
    • (2008) Physiol Behav , vol.94 , pp. 276-284
    • Volman, J.J.1    Ramakers, J.D.2    Plat, J.3
  • 12
    • 78751560494 scopus 로고    scopus 로고
    • Pathogen recognition by the innate immune system
    • 10.3109/08830185.2010.529976 21235323
    • Pathogen recognition by the innate immune system. Kumar H, Kawai T, Akira S, Int Rev Immunol 2011 30 16 34 10.3109/08830185.2010.529976 21235323
    • (2011) Int Rev Immunol , vol.30 , pp. 16-34
    • Kumar, H.1    Kawai, T.2    Akira, S.3
  • 13
    • 27144540463 scopus 로고    scopus 로고
    • Are innate immune signaling pathways in plants and animals conserved?
    • 10.1038/ni1253 16177805
    • Are innate immune signaling pathways in plants and animals conserved? Ausubel FM, Nat Immunol 2005 6 973 979 10.1038/ni1253 16177805
    • (2005) Nat Immunol , vol.6 , pp. 973-979
    • Ausubel, F.M.1
  • 14
    • 20744438481 scopus 로고    scopus 로고
    • Innate and acquired plasticity of the intestinal immune system
    • 10.1007/s00018-005-5032-4 15971103
    • Innate and acquired plasticity of the intestinal immune system. Didierlaurent A, Simonet M, Sirard JC, Cell Mol Life Sci 2005 62 1285 1287 10.1007/s00018-005-5032-4 15971103
    • (2005) Cell Mol Life Sci , vol.62 , pp. 1285-1287
    • Didierlaurent, A.1    Simonet, M.2    Sirard, J.C.3
  • 15
  • 17
    • 0023077050 scopus 로고
    • Specificity of membrane complement receptor type three (CR3) for beta-glucans
    • 3040332
    • Specificity of membrane complement receptor type three (CR3) for beta-glucans. Ross GD, Cain JA, Myones BL, Newman SL, Lachmann PJ, Complement 1987 4 61 74 3040332
    • (1987) Complement , vol.4 , pp. 61-74
    • Ross, G.D.1    Cain, J.A.2    Myones, B.L.3    Newman, S.L.4    Lachmann, P.J.5
  • 18
    • 77953464750 scopus 로고    scopus 로고
    • (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages
    • (1,3)-beta-glucans activate both dectin-1 and NLRP3 inflammasome in human macrophages. Kankkunen P, Teirila L, Rintahaka J, Alenius H, Wolff H, Matikainen S, J Immunol 2011 184 6335 6342
    • (2011) J Immunol , vol.184 , pp. 6335-6342
    • Kankkunen, P.1    Teirila, L.2    Rintahaka, J.3    Alenius, H.4    Wolff, H.5    Matikainen, S.6
  • 19
    • 0019378352 scopus 로고
    • Glycan stimulation of macrophages in vitro
    • 10.1016/0014-4827(81)90413-4 7447985
    • Glycan stimulation of macrophages in vitro. Seljelid R, Bögwald J, Lundwall A, Exp Cell Res 1981 131 121 129 10.1016/0014-4827(81)90413-4 7447985
    • (1981) Exp Cell Res , vol.131 , pp. 121-129
    • Seljelid, R.1    Bögwald, J.2    Lundwall, A.3
  • 20
    • 0029585440 scopus 로고
    • Mitogenic activity of particulate yeast b-(1,)-D-glucan and its water-soluble derivates
    • 10.1016/0141-8130(96)81839-3 8789333
    • Mitogenic activity of particulate yeast b-(1,)-D-glucan and its water-soluble derivates. Sandula J, Machnova E, Int J Biol Macromol 1995 17 323 327 10.1016/0141-8130(96)81839-3 8789333
    • (1995) Int J Biol Macromol , vol.17 , pp. 323-327
    • Sandula, J.1    Machnova, E.2
  • 21
    • 0028127061 scopus 로고
    • A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients
    • 10.1001/archsurg.1994.01420350102014 7979954
    • A phase II multicenter, double-blind, randomized, placebo-controlled study of three dosages of an immunomodulator (PGG-glucan) in high-risk surgical patients. Babineau TJ, Hackford A, Kenler A, Bistrian B, Forse RA, Fairchild PG, Heard S, Keroack M, Caushaj P, Benotti P, Arch Surg 1994 129 1204 1210 10.1001/archsurg.1994.01420350102014 7979954
    • (1994) Arch Surg , vol.129 , pp. 1204-1210
    • Babineau, T.J.1    Hackford, A.2    Kenler, A.3    Bistrian, B.4    Forse, R.A.5    Fairchild, P.G.6    Heard, S.7    Keroack, M.8    Caushaj, P.9    Benotti, P.10
  • 22
    • 0027986554 scopus 로고
    • Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients
    • 10.1097/00000658-199411000-00002 7979607
    • Randomized phase I/II trial of a macrophage-specific immunomodulator (PGG-glucan) in high-risk surgical patients. Babineau TJ, Marcello P, Swails W, Kenler A, Bistrian B, Forse RA, Ann Surg 1994 220 601 609 10.1097/00000658- 199411000-00002 7979607
    • (1994) Ann Surg , vol.220 , pp. 601-609
    • Babineau, T.J.1    Marcello, P.2    Swails, W.3    Kenler, A.4    Bistrian, B.5    Forse, R.A.6
  • 23
    • 0027367184 scopus 로고
    • Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan)
    • 8211583
    • Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). de Felippe JJ, Maciel FM, Soares AM, Mendes NF, Surg Gynecol Obstet 1993 177 383 8211583
    • (1993) Surg Gynecol Obstet , vol.177 , pp. 383
    • De Felippe, J.J.1    Maciel, F.M.2    Soares, A.M.3    Mendes, N.F.4
  • 24
    • 0024423872 scopus 로고
    • Immunomodulation by orally administered beta-glucan in mice
    • 10.1016/0192-0561(89)90130-6 2599714
    • Immunomodulation by orally administered beta-glucan in mice. Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T, Int J Immunopharmacol 1989 11 761 769 10.1016/0192-0561(89)90130-6 2599714
    • (1989) Int J Immunopharmacol , vol.11 , pp. 761-769
    • Suzuki, I.1    Hashimoto, K.2    Ohno, N.3    Tanaka, H.4    Yadomae, T.5
  • 25
    • 3142702164 scopus 로고    scopus 로고
    • Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models
    • 10.4049/jimmunol.173.2.797 15240666
    • Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cheung NK, Ross GD, J Immunol 2004 173 797 806 10.4049/jimmunol.173.2.797 15240666
    • (2004) J Immunol , vol.173 , pp. 797-806
    • Hong, F.1    Yan, J.2    Baran, J.T.3    Allendorf, D.J.4    Hansen, R.D.5    Ostroff, G.R.6    Xing, P.X.7    Cheung, N.K.8    Ross, G.D.9
  • 26
    • 0025164502 scopus 로고
    • Effect of orally administered beta-glucan on macrophage function in mice
    • 10.1016/0192-0561(90)90105-V 2272730
    • Effect of orally administered beta-glucan on macrophage function in mice. Suzuki I, Tanaka H, Kinoshita A, Oikawa S, Osawa M, Yadomae T, Int J Immunopharmacol 1990 12 675 684 10.1016/0192-0561(90)90105-V 2272730
    • (1990) Int J Immunopharmacol , vol.12 , pp. 675-684
    • Suzuki, I.1    Tanaka, H.2    Kinoshita, A.3    Oikawa, S.4    Osawa, M.5    Yadomae, T.6
  • 27
    • 77950289478 scopus 로고    scopus 로고
    • Effect of Biolex Beta-HP on phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats intoxicated by cyclophosphamide
    • 21077449
    • Effect of Biolex Beta-HP on phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats intoxicated by cyclophosphamide. Wojcik R, Pol J Vet Sci 2010 13 181 188 21077449
    • (2010) Pol J Vet Sci , vol.13 , pp. 181-188
    • Wojcik, R.1
  • 28
    • 77954630630 scopus 로고    scopus 로고
    • Effect of Biolex β-HP on selected parameters of specific and non-specific humoral and cellular immunity in rats
    • Effect of Biolex β-HP on selected parameters of specific and non-specific humoral and cellular immunity in rats. Małaczewska J, Wójcik R, Jung L, Siwicki AK, Bull Vet Inst Pulawy 2010 54 75 80
    • (2010) Bull Vet Inst Pulawy , vol.54 , pp. 75-80
    • Małaczewska, J.1    Wójcik, R.2    Jung, L.3    Siwicki, A.K.4
  • 29
    • 0038368804 scopus 로고    scopus 로고
    • Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan
    • 10.1016/S0008-8749(03)00061-3 12742376
    • Immunopotentiation of intraepithelial lymphocytes in the intestine by oral administrations of beta-glucan. Tsukada C, Yokoyama H, Miyaji C, Ishimoto Y, Kawamura H, Abo T, Cell Immunol 2003 221 1 5 10.1016/S0008-8749(03)00061-3 12742376
    • (2003) Cell Immunol , vol.221 , pp. 1-5
    • Tsukada, C.1    Yokoyama, H.2    Miyaji, C.3    Ishimoto, Y.4    Kawamura, H.5    Abo, T.6
  • 31
    • 79959526149 scopus 로고    scopus 로고
    • Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans
    • 10.1182/blood-2011-02-339812 21531981
    • Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived beta-glucans. Qi C, Cai Y, Gunn L, Ding C, Li B, Kloecker G, Qian K, Vasilakos J, Saijo S, Iwakura Y, Yannelli JR, Yan J, Blood 2011 117 6825 6836 10.1182/blood-2011-02-339812 21531981
    • (2011) Blood , vol.117 , pp. 6825-6836
    • Qi, C.1    Cai, Y.2    Gunn, L.3    Ding, C.4    Li, B.5    Kloecker, G.6    Qian, K.7    Vasilakos, J.8    Saijo, S.9    Iwakura, Y.10    Yannelli, J.R.11    Yan, J.12
  • 32
    • 41149133426 scopus 로고    scopus 로고
    • Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching
    • 10.1124/jpet.107.133124 18171906
    • Differential high-affinity interaction of dectin-1 with natural or synthetic glucans is dependent upon primary structure and is influenced by polymer chain length and side-chain branching. Adams EL, Rice PJ, Graves B, Ensley HE, Yu H, Brown GD, Gordon S, Monteiro MA, Papp-Szabo E, Lowman DW, Power TD, Wempe MF, Williams DL, J Pharmacol Exp Ther 2008 325 115 123 10.1124/jpet.107.133124 18171906
    • (2008) J Pharmacol Exp Ther , vol.325 , pp. 115-123
    • Adams, E.L.1    Rice, P.J.2    Graves, B.3    Ensley, H.E.4    Yu, H.5    Brown, G.D.6    Gordon, S.7    Monteiro, M.A.8    Papp-Szabo, E.9    Lowman, D.W.10    Power, T.D.11    Wempe, M.F.12    Williams, D.L.13
  • 34
    • 69249228499 scopus 로고    scopus 로고
    • Effect of β-1,3/1,6-D-glucan on the phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats
    • Effect of β-1,3/1,6-D-glucan on the phagocytic activity and oxidative metabolism of peripheral blood granulocytes and monocytes in rats. Wójcik R, Janowska E, Malaczewska J, Siwicki AK, Bull Vet Inst Pulawy 2009 53 241 246
    • (2009) Bull Vet Inst Pulawy , vol.53 , pp. 241-246
    • Wójcik, R.1    Janowska, E.2    Malaczewska, J.3    Siwicki, A.K.4
  • 35
    • 84881356857 scopus 로고    scopus 로고
    • The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs
    • 10.1556/AVet.2013.015 23921342
    • The effectiveness of natural and synthetic immunomodulators in the treatment of inflammatory bowel disease in dogs. Rychlik A, Nieradka R, Kander M, Nowicki M, Wdowiak M, Kolodziejska-Sawerska A, Acta Vet Hung 2013 61 297 308 10.1556/AVet.2013.015 23921342
    • (2013) Acta Vet Hung , vol.61 , pp. 297-308
    • Rychlik, A.1    Nieradka, R.2    Kander, M.3    Nowicki, M.4    Wdowiak, M.5    Kolodziejska-Sawerska, A.6
  • 36
    • 0025864320 scopus 로고
    • Psychological stress and susceptibility to the common cold
    • 10.1056/NEJM199108293250903 1713648
    • Psychological stress and susceptibility to the common cold. Cohen S, Tyrrell DA, Smith AP, N Engl J Med 1991 325 606 612 10.1056/NEJM199108293250903 1713648
    • (1991) N Engl J Med , vol.325 , pp. 606-612
    • Cohen, S.1    Tyrrell, D.A.2    Smith, A.P.3
  • 37
    • 85046520814 scopus 로고
    • Negative life events, perceived stress, negative affect, and susceptibility to the common cold
    • 8421249
    • Negative life events, perceived stress, negative affect, and susceptibility to the common cold. Cohen S, Tyrrell DA, Smith AP, J Pers Soc Psychol 1993 64 131 140 8421249
    • (1993) J Pers Soc Psychol , vol.64 , pp. 131-140
    • Cohen, S.1    Tyrrell, D.A.2    Smith, A.P.3
  • 38
    • 84890553236 scopus 로고    scopus 로고
    • Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: A double-blind, randomized, placebo-controlled, multicentric study in healthy subjects
    • Epub ahead of print
    • Yeast (1,3)-(1,6)-beta-glucan helps to maintain the body's defence against pathogens: a double-blind, randomized, placebo-controlled, multicentric study in healthy subjects. Auinger A, Riede L, Bothe G, Busch R, Gruenwald J, Eur J Nutr 2013 Epub ahead of print
    • (2013) Eur J Nutr
    • Auinger, A.1    Riede, L.2    Bothe, G.3    Busch, R.4    Gruenwald, J.5
  • 39
    • 84890549197 scopus 로고    scopus 로고
    • A double-blind, randomized, placebo-controlled nutritional study using an insoluble yeast beta-glucan to improve the immune defense system
    • 10.4236/fns.2012.36100
    • A double-blind, randomized, placebo-controlled nutritional study using an insoluble yeast beta-glucan to improve the immune defense system. Graubaum H-J, Busch R, Stier H, Gruenwald J, Food Nutr Sci 2012 3 738 746 10.4236/fns.2012.36100
    • (2012) Food Nutr Sci , vol.3 , pp. 738-746
    • Graubaum, H.-J.1    Busch, R.2    Stier, H.3    Gruenwald, J.4
  • 40
    • 65449168381 scopus 로고    scopus 로고
    • Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans
    • 10.1016/j.nutres.2009.03.002 19410976
    • Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans. Kohl A, Gogebakan O, Mohlig M, Osterhoff M, Isken F, Pfeiffer AF, Weickert MO, Nutr Res 2009 29 248 254 10.1016/j.nutres.2009.03.002 19410976
    • (2009) Nutr Res , vol.29 , pp. 248-254
    • Kohl, A.1    Gogebakan, O.2    Mohlig, M.3    Osterhoff, M.4    Isken, F.5    Pfeiffer, A.F.6    Weickert, M.O.7
  • 41
    • 0032819217 scopus 로고    scopus 로고
    • Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group
    • 10.1001/archsurg.134.9.977 10487593
    • Effect of PGG-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations. Betafectin Gastrointestinal Study Group. Dellinger EP, Babineau TJ, Bleicher P, Kaiser AB, Seibert GB, Postier RG, Vogel SB, Norman J, Kaufman D, Galandiuk S, Condon RE, Arch Surg 1999 134 977 983 10.1001/archsurg.134.9.977 10487593
    • (1999) Arch Surg , vol.134 , pp. 977-983
    • Dellinger, E.P.1    Babineau, T.J.2    Bleicher, P.3    Kaiser, A.B.4    Seibert, G.B.5    Postier, R.G.6    Vogel, S.B.7    Norman, J.8    Kaufman, D.9    Galandiuk, S.10    Condon, R.E.11
  • 43
    • 72249095793 scopus 로고    scopus 로고
    • Effect of beta 1,3/1,6 glucan on upper respiratory tract infection symptoms and mood state in marathon athlets
    • 24149590
    • Effect of beta 1,3/1,6 glucan on upper respiratory tract infection symptoms and mood state in marathon athlets. Talbott S, Talbott J, J Sports Sci Med 2009 8 509 515 24149590
    • (2009) J Sports Sci Med , vol.8 , pp. 509-515
    • Talbott, S.1    Talbott, J.2
  • 44
    • 77950615734 scopus 로고    scopus 로고
    • Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological well-being in moderate to highly-stressed subjects
    • Beta 1,3/1,6 glucan decreases upper respiratory tract infection symptoms and improves psychological well-being in moderate to highly-stressed subjects. Talbott S, Talbott J, Agro Food Industry Hi-Tech 2010 21 21 24
    • (2010) Agro Food Industry Hi-Tech , vol.21 , pp. 21-24
    • Talbott, S.1    Talbott, J.2
  • 45
    • 84900435652 scopus 로고    scopus 로고
    • Beta-glucan supplement reduces URTIs (Upper Respiratory Tract Infections) and improves mood state in healthy stressed subjects
    • Beta-glucan supplement reduces URTIs (Upper Respiratory Tract Infections) and improves mood state in healthy stressed subjects. Talbott S, Talbott J, Cox D, FASEB J 2010 24 922
    • (2010) FASEB J , vol.24 , pp. 922
    • Talbott, S.1    Talbott, J.2    Cox, D.3
  • 46
    • 84885771707 scopus 로고    scopus 로고
    • Baker's yeast beta-glucan supplementation increases monocytes and cytokines post-exercise: Implications for infection risk?
    • 10.1017/S0007114512001407 22575076
    • Baker's yeast beta-glucan supplementation increases monocytes and cytokines post-exercise: implications for infection risk? Carpenter KC, Breslin WL, Davidson T, Adams A, McFarlin BK, Br J Nutr 2013 109 3 478 486 10.1017/S0007114512001407 22575076
    • (2013) Br J Nutr , vol.109 , Issue.3 , pp. 478-486
    • Carpenter, K.C.1    Breslin, W.L.2    Davidson, T.3    Adams, A.4    McFarlin, B.K.5
  • 47
    • 84860620037 scopus 로고    scopus 로고
    • Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections
    • Epub ahead of print
    • Influence of yeast-derived 1,3/1,6 glucopolysaccharide on circulating cytokines and chemokines with respect to upper respiratory tract infections. Fuller R, Butt H, Noakes PS, Kenyon J, Yam TS, Calder PC, Nutrition 2012 Epub ahead of print
    • (2012) Nutrition
    • Fuller, R.1    Butt, H.2    Noakes, P.S.3    Kenyon, J.4    Yam, T.S.5    Calder, P.C.6
  • 48
    • 84876334060 scopus 로고    scopus 로고
    • Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women
    • 10.1080/07315724.2012.10720441 23378458
    • Baker's yeast beta-glucan supplement reduces upper respiratory symptoms and improves mood state in stressed women. Talbott SM, Talbott JA, J Am Coll Nutr 2012 31 295 300 10.1080/07315724.2012.10720441 23378458
    • (2012) J Am Coll Nutr , vol.31 , pp. 295-300
    • Talbott, S.M.1    Talbott, J.A.2
  • 49
    • 33644829209 scopus 로고    scopus 로고
    • Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers
    • 10.1111/j.1365-2249.2005.02962.x 16367935
    • Oral administration of a new soluble branched beta-1,3-D-glucan is well tolerated and can lead to increased salivary concentrations of immunoglobulin A in healthy volunteers. Lehne G, Haneberg B, Gaustad P, Johansen PW, Preus H, Abrahamsen TG, Clin Exp Immunol 2006 143 65 69 10.1111/j.1365-2249.2005.02962.x 16367935
    • (2006) Clin Exp Immunol , vol.143 , pp. 65-69
    • Lehne, G.1    Haneberg, B.2    Gaustad, P.3    Johansen, P.W.4    Preus, H.5    Abrahamsen, T.G.6
  • 50
    • 84900442303 scopus 로고    scopus 로고
    • EFSA panel on dietetic products, nutrition and allergies (NDA): Scientific opinion on the substantiation of a health claim related to Yestimun® and immune responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    • EFSA
    • EFSA panel on dietetic products, nutrition and allergies (NDA): scientific opinion on the substantiation of a health claim related to Yestimun® and immune responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA, EFSA J 2010 8 11
    • (2010) EFSA J , vol.8 , pp. 11
  • 51
    • 84928109268 scopus 로고    scopus 로고
    • EFSA panel on dietetic products, nutrition and allergies (NDA): Scientific opinion on the substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006
    • EFSA
    • EFSA panel on dietetic products, nutrition and allergies (NDA): scientific opinion on the substantiation of a health claim related to Yestimun® and defence against pathogens in the upper respiratory tract pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA, EFSA Journal 2013 11 12
    • (2013) EFSA Journal , vol.11 , pp. 12
  • 55
    • 85078379445 scopus 로고    scopus 로고
    • Scientific Opinion on the safety of 'yeast beta-glucans' as a Novel Food ingredient
    • EFSA Panel on Dietetic Products NaAN [2122
    • Scientific Opinion on the safety of 'yeast beta-glucans' as a Novel Food ingredient. EFSA Panel on Dietetic Products NaAN, EFSA J 2011 9 2137 [2122 pp.]
    • (2011) EFSA J , vol.9 , pp. 2137
  • 56
    • 34547127390 scopus 로고    scopus 로고
    • Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats
    • 10.1016/j.fct.2007.03.013 17493735
    • Toxicological assessment of a particulate yeast (1,3/1,6)-beta-D-glucan in rats. Babicek K, Cechova I, Simon RR, Harwood M, Cox DJ, Food Chem Toxicol 2007 45 1719 1730 10.1016/j.fct.2007.03.013 17493735
    • (2007) Food Chem Toxicol , vol.45 , pp. 1719-1730
    • Babicek, K.1    Cechova, I.2    Simon, R.R.3    Harwood, M.4    Cox, D.J.5
  • 57
    • 0018612504 scopus 로고
    • Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan
    • 10.1002/ijc.2910240613 397198
    • Comparative tumor-inhibitory and anti-bacterial activity of soluble and particulate glucan. Di Luzio NR, Williams DL, McNamee RB, Edwards BF, Kitahama A, Int J Cancer 1979 24 773 779 10.1002/ijc.2910240613 397198
    • (1979) Int J Cancer , vol.24 , pp. 773-779
    • Di Luzio, N.R.1    Williams, D.L.2    McNamee, R.B.3    Edwards, B.F.4    Kitahama, A.5
  • 58
    • 0029097460 scopus 로고
    • Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae
    • Preclinical and clinical evaluation of carbohydrate immunopharmaceuticals in the prevention of sepsis and septic sequelae. Williams DL, Mueller A, Browder W, J Endotoxin Res 1995 2 203 208
    • (1995) J Endotoxin Res , vol.2 , pp. 203-208
    • Williams, D.L.1    Mueller, A.2    Browder, W.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.